Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)

Acute myeloid leukemia (AML) with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) has a very poor prognosis. Determinants of clinical outcomes and optimal treatment remain uncertain. We retrospectively reviewed 108 cases of AML with inv(3)/t(3;3) and evaluated clinicopathological characteristics and clinical out...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard-Carpentier, Guillaume, Rausch, Caitlin R., Sasaki, Koji, Hammond, Danielle, Morita, Kiyomi, Takahashi, Koichi, Tang, Guilin, Kanagal-Shamanna, Rashmi, Bhalla, Kapil, Dinardo, Courtney D., Borthakur, Gautam, Pemmaraju, Naveen, Shpall, Elizabeth J., Alousi, Amin, Daver, Naval G., Garcia-Manero, Guillermo, Konopleva, Marina Y., Ravandi, Farhad, Kantarjian, Hagop M., Kadia, Tapan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Acute Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483357/
https://www.ncbi.nlm.nih.gov/pubmed/36951163
http://dx.doi.org/10.3324/haematol.2022.282030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483357/
https://www.ncbi.nlm.nih.gov/pubmed/36951163
http://dx.doi.org/10.3324/haematol.2022.282030

Ejemplares similares